title: Pregabalin in patients with antidepressant treatment-resistant somatoform disorders: a case series.
authors.forename: Daniel
authors.initials: D
authors.lastname: Harnack
authors.forename: Michael
authors.initials: M
authors.lastname: Scheel
authors.forename: Adrian
authors.initials: A
authors.lastname: Mundt
authors.forename: Andreas
authors.initials: A
authors.lastname: Kupsch
authors.forename: Andreas
authors.initials: A
authors.lastname: Heinz
authors.forename: Andreas
authors.initials: A
authors.lastname: Ströhle
mesh_terms: D000328:Adult; D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy*; D010147:Pain Measurement; D000069583:Pregabalin; D013001:Somatoform Disorders / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000700:Analgesics; D000928:Antidepressive Agents; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid